⚠️ Educational purposes only. PeptideIQ does not constitute medical advice, diagnosis, or treatment. Peptide therapy should only be pursued under the guidance of a licensed medical provider. Many peptides discussed are research-grade compounds not approved by the FDA. Always verify current legal status in your jurisdiction before use.
← Back to library
Thymosin α-1
Thymosin Alpha-1
Strong RCTIntl. Approved
The strongest clinically validated immune-modulating peptide, approved in 30+ countries for viral infections and immune deficiency.
Mechanism of action
T-cell activation, innate immune enhancement, cytokine modulation, anti-tumor activity
Primary benefits
- ✓Enhanced immunity
- ✓Anti-viral
- ✓Anti-tumor activity
- ✓Immune modulation
- ✓Chronic illness recovery
Dosing
Beginner
0.8-1.6 mg twice weekly
Intermediate
1.6 mg twice weekly
Advanced
1.6-3.2 mg twice weekly
Frequency: 2-3x per week
Timing: Any time of day
Route: Subcutaneous injection
Cycling protocol
Duration
4-6 weeks
Pattern
Ongoing under supervision for chronic conditions
Break after
4 weeks minimum
Important warnings
- ⚠️FDA-approved in 30+ countries but not USA as standalone
- ⚠️Very well tolerated — minimal side effect profile
- ⚠️Use under medical supervision for immune conditions